Jin Chao Liu

Jin Chao Liu

Auto-generated profile, based on publicly available information

Jin Chao Liu

Department of Interventional Radiology, Puyang Oilfield General Hospital, Puyang, Henan Province, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2020 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
ZWZi Wen Wang
Zi Wen Wang
JLJin Chao Liu
Jin Chao Liu
FZFang Zhao
Fang Zhao
WZWen Guang Zhang
Wen Guang Zhang
XDXu Hua Duan
Xu Hua Duan
JRJianzhuang Ren
Jianzhuang Ren
Background and Aim. Upper gastrointestinal bleeding is a threat to patients with gastric varices (GVs). Previous studies have concluded that both transjugular intrahepatic portosystemic shunt (TIPS) and balloon-occluded retrograde transvenous obliteration (BRTO) are effective treatments for patients with GV. We aimed to compare the efficiency and outcomes of these two procedures in GV patients through meta-analysis.Methods. The PubMed, Cochrane Library, EMBASE, and Web of Science databases were searched using the keywords: GV, bleeding, TIPS, and BRTO to identify relevant randomized controlled trials and cohort studies. The overall survival (OS) rate, imminent haemostasis rate, rebleeding rate, technical success rate, procedure complication rate (hepatic encephalopathy and aggravated ascites), and Child-Pugh score were evaluated. Randomized clinical trials and cohort studies comparing TIPS and BRTO for GV due to portal hypertension were included in our meta-analysis. Two independent reviewers performed data extraction and assessed the study quality. A meta-analysis was performed to calculate risk ratios (RRs), mean differences (MDs), and 95% CIs using random effects models.Results. A total of nine studies fulfilled the inclusion criteria. There was a significant difference between TIPS and BRTO in the OS rate (RR, 0.81 (95% CI, 0.66 to 0.98);P=0.03) and rebleeding rate (RR, 2.61 (95% CI, 1.75 to 3.90);P<0.00001). TIPS had a higher incidence rate of hepatic encephalopathy (RR, 16.11 (95% CI, 7.13 to 36.37);P<0.00001). There was no significant difference between TIPS and BRTO in the immediate haemostasis rate (RR, 0.99 (95% CI, 0.89 to 1.10);P=0.84), technical success rate (RR, 1.06 (95% CI, 0.98 to 1.16);P=0.16), aggravated ascites rate (RR, 0.60 (95% CI, 0.33 to 1.09);P=0.10), or Child-Pugh change (MD, 0.22 (95% CI, −0.21 to 0.65);P=0.31).Conclusions. In this meta-analysis, BRTO brought more benefits to patients, with a higher OS rate and lower rebleeding rate. BRTO is a feasible method for GVB.

30 July 2025 in Clinics
Verified
Journal Article
Open access
ZWZiwen Wang
Ziwen Wang
FZFang Zhao
Fang Zhao
JLJin-Chao Liu
Jin-Chao Liu
DLDan-Feng Li
Dan-Feng Li
Observational studies have indicated a potential association between serum uric acid levels and the risk of intracerebral hemorrhage and subarachnoid hemorrhage. To explore whether this relationship is causal, the authors performed a two-sample Mendelian randomization analysis. The authors sourced data on single-nucleotide polymorphisms related to serum uric acid levels from the European Bioinformatics Institute ‒ Association database, along with information on intracerebral hemorrhage and subarachnoid hemorrhage from the same repository. The primary analysis for the Mendelian Randomization was conducted using the inverse variance weighted method, accompanied by sensitivity analyses to validate the findings. The Mendelian Randomization analysis revealed a positive causal association between serum uric acid and the risk of ICH Odds Ratio (OR = 1.29; 95 % CI 1.07-1.54, p = 0.007) and SAH (OR = 1.27; 95 % CI 1.04-1.54, p = 0.018). The present research offers direct evidence suggesting that higher serum uric acid levels could raise the risk of Intracerebral Hemorrhage (ICH) and Subarachnoid Hemorrhage (SAH). Additional investigations are needed to explore the mechanisms by which serum uric acid influences these types of hemorrhagic events.